TY - JOUR AU - Grimm, P. AU - Billiet, I. AU - Bostwick, D. AU - Dicker, A. P. AU - Frank, S. AU - Immerzeel, J. AU - Keyes, M. AU - Kupelian, P. AU - Lee, W. R. AU - Machtens, S. AU - Mayadev, J. AU - Moran, B. J. AU - Merrick, G. AU - Millar, J. AU - Roach, M. AU - Stock, R. AU - Shinohara, K. AU - Scholz, M. AU - Weber, E. AU - Zietman, A. AU - Zelefsky, M. AU - Wong, J. AU - Wentworth, S. AU - Vera, R. AU - Langley, S. PY - 2012 DA - 2012// TI - Comparative analysis of prostate-specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy. Results from the Prostate Cancer Results Study Group JO - BJU Int VL - 109 UR - https://doi.org/10.1111/j.1464-410X.2011.10827.x DO - 10.1111/j.1464-410X.2011.10827.x ID - Grimm2012 ER - TY - JOUR AU - Taira, A. V. 1. AU - Merrick, G. S. AU - Butler, W. M. AU - Galbreath, R. W. AU - Lief, J. AU - Adamovich, E. AU - Wallner, K. E. PY - 2011 DA - 2011// TI - Long-term outcome for clinically localized prostate cancer treated with permanent interstitial brachytherapy JO - Int J Radiat Oncol Biol Phys VL - 79 UR - https://doi.org/10.1016/j.ijrobp.2010.01.005 DO - 10.1016/j.ijrobp.2010.01.005 ID - Taira2011 ER - TY - JOUR AU - Sylvester, J. E. AU - Grimm, P. D. AU - Blasko, J. C. AU - Millar, J. AU - Orio, P. F. AU - Skoglund, S. AU - Galbreath, R. W. AU - Merrick, G. PY - 2007 DA - 2007// TI - 15-Year biochemical relapse free survival in clinical Stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience JO - Int J Radiat Oncol Biol Phys VL - 67 UR - https://doi.org/10.1016/j.ijrobp.2006.07.1382 DO - 10.1016/j.ijrobp.2006.07.1382 ID - Sylvester2007 ER - TY - JOUR AU - Hull, G. W. AU - Rabbani, F. AU - Abbas, F. AU - Wheeler, T. M. AU - Kattan, M. W. AU - Scardino, P. T. PY - 2002 DA - 2002// TI - Cancer control with radical prostatectomy alone in 1,000 consecutive patients JO - J Urol VL - 167 UR - https://doi.org/10.1016/S0022-5347(01)69079-7 DO - 10.1016/S0022-5347(01)69079-7 ID - Hull2002 ER - TY - JOUR AU - Han, M. 1. AU - Partin, A. W. AU - Zahurak, M. AU - Piantadosi, S. AU - Epstein, J. I. AU - Walsh, P. C. PY - 2003 DA - 2003// TI - Biochemical (prostate specific antigen) recurrence probability following radical prostatectomy for clinically localized prostate cancer JO - J Urol VL - 169 UR - https://doi.org/10.1016/S0022-5347(05)63946-8 DO - 10.1016/S0022-5347(05)63946-8 ID - Han2003 ER - TY - JOUR AU - Kuban, D. A. 1. AU - Levy, L. B. AU - Cheung, M. R. AU - Lee, A. K. AU - Choi, S. AU - Frank, S. AU - Pollack, A. PY - 2011 DA - 2011// TI - Long-term failure patterns and survival in a randomized dose-escalation trial for prostate cancer. Who dies of disease? JO - Int J Radiat Oncol Biol Phys VL - 79 UR - https://doi.org/10.1016/j.ijrobp.2010.01.006 DO - 10.1016/j.ijrobp.2010.01.006 ID - Kuban2011 ER - TY - JOUR AU - Cookson, M. S. AU - Aus, G. AU - Burnett, A. L. AU - Canby-Hagino, E. D. AU - D’Amico, A. V. AU - Dmochowski, R. R. AU - Eton, D. T. AU - Forman, J. D. AU - Goldenberg, S. L. AU - Hernandez, J. AU - Higano, C. S. AU - Kraus, S. R. AU - Moul, J. W. AU - Tangen, C. AU - Thrasher, J. B. AU - Thompson, I. PY - 2007 DA - 2007// TI - Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes JO - J Urol VL - 177 UR - https://doi.org/10.1016/j.juro.2006.10.097 DO - 10.1016/j.juro.2006.10.097 ID - Cookson2007 ER - TY - JOUR AU - Roach, M. AU - Hanks, G. AU - Thames, H. AU - Schellhammer, P. AU - Shipley, W. U. AU - Sokol, G. H. AU - Sandler, H. PY - 2006 DA - 2006// TI - Defining biochemical failure following radiotherapy with or without hormonal therapy in men with clinically localized prostate cancer: recommendations of the RTOG-ASTRO Phoenix Consensus Conference JO - Int J Radiat Oncol Biol Phys VL - 65 UR - https://doi.org/10.1016/j.ijrobp.2006.04.029 DO - 10.1016/j.ijrobp.2006.04.029 ID - Roach2006 ER - TY - BOOK PY - 2007 DA - 2007// TI - Guideline, Guideline for the Management of Clinically Localized Prostate Cancer ID - ref9 ER - TY - STD TI - European Association of Urology (EAU): Guideline. [http://www.uroweb.org] [] UR - http://www.uroweb.org ID - ref10 ER - TY - STD TI - National Comprehensive Cancer Network (NCCN): Clinical Practice Guidelines in Oncology, Prostate Cancer. [http://www.nccn.org] [] UR - http://www.nccn.org ID - ref11 ER - TY - JOUR AU - D’Amico, A. V. 1. AU - Whittington, R. AU - Malkowicz, S. B. AU - Schultz, D. AU - Blank, K. AU - Broderick, G. A. AU - Tomaszewski, J. E. AU - Renshaw, A. A. AU - Kaplan, I. AU - Beard, C. J. AU - Wein, A. PY - 1998 DA - 1998// TI - Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer JO - JAMA VL - 280 UR - https://doi.org/10.1001/jama.280.11.969 DO - 10.1001/jama.280.11.969 ID - D’Amico1998 ER - TY - JOUR AU - Tanaka, N. AU - Asakawa, I. AU - Kondo, H. AU - Tanaka, M. AU - Fujimoto, K. AU - Hasegawa, M. AU - Konishi, N. AU - Hirao, Y. PY - 2009 DA - 2009// TI - Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: our first series of 100 patients JO - Int J Urol VL - 16 UR - https://doi.org/10.1111/j.1442-2042.2008.02172.x DO - 10.1111/j.1442-2042.2008.02172.x ID - Tanaka2009 ER - TY - JOUR AU - Stock, R. G. 1. AU - Stone, N. N. AU - Cesaretti, J. A. AU - Rosenstein, B. S. PY - 2006 DA - 2006// TI - Biologically effective dose values for prostate brachytherapy: effects on PSA failure and posttreatment biopsy results JO - Int J Radiat Oncol Biol Phys VL - 64 UR - https://doi.org/10.1016/j.ijrobp.2005.07.981 DO - 10.1016/j.ijrobp.2005.07.981 ID - Stock2006 ER - TY - JOUR AU - Critz, F. A. 1. AU - Benton, J. B. AU - Shrake, P. AU - Merlin, M. L. PY - 2013 DA - 2013// TI - 25-Year disease-free survival rate after irradiation for prostate cancer calculated with the prostate specific antigen definition of recurrence used for radical prostatectomy JO - J Urol VL - 189 UR - https://doi.org/10.1016/j.juro.2012.10.061 DO - 10.1016/j.juro.2012.10.061 ID - Critz2013 ER - TY - JOUR AU - Stone, N. N. AU - Stock, R. G. AU - Cesaretti, J. A. AU - Unger, P. PY - 2010 DA - 2010// TI - Local control following permanent prostate brachytherapy: effect of high biologically effective dose on biopsy results and oncologic outcomes JO - Int J Radiat Oncol Biol Phys VL - 76 UR - https://doi.org/10.1016/j.ijrobp.2009.01.078 DO - 10.1016/j.ijrobp.2009.01.078 ID - Stone2010 ER - TY - JOUR AU - Nielsen, M. E. AU - Makarov, D. V. AU - Humphreys, E. AU - Mangold, L. AU - Partin, A. W. AU - Walsh, P. C. PY - 2008 DA - 2008// TI - Is it possible to compare PSA recurrence-free survival after surgery and radiotherapy using revised ASTRO criterion–“nadir + 2”? JO - Urology VL - 72 UR - https://doi.org/10.1016/j.urology.2007.10.053 DO - 10.1016/j.urology.2007.10.053 ID - Nielsen2008 ER -